Skip to main content

Table 4 v-Src aggressive tumor gene signature.

From: Cellular processes of v-Src transformation revealed by gene profiling of primary cells - Implications for human cancer

Gene symbol

Gene name

ATAD3A

ATPase family, AAA domain containing 3A

C13orf3

chromosome 13 open reading frame 3

CCNA2

cyclin A2

CCNE2

cyclin E2

CEP55

centrosomal protein 55 kDa

CSTA

cystatin A (stefin A)

E2F8

E2F transcription factor 8

EAF2

ELL associated factor 2

EXO1

exonuclease 1

GAR1

GAR1 ribonucleoprotein homolog (yeast)

HELLS

helicase, lymphoid-specific

HMOX1

heme oxygenase (decycling) 1

HSP90AB1

heat shock protein 90 kDa alpha (cytosolic), class B member 1

IL8

Interleukin 8

ITGA4

integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)

KIF11

kinesin family member 11

KIF2A

kinesin heavy chain member 2A

LBR

lamin B receptor

MPP1

Membrane protein, palmitoylated 1, 55 kDa

NASP

nuclear autoantigenic sperm protein (histone-binding)

NOC2L

nucleolar complex associated 2 homolog (S. cerevisiae)

NOP14

NOP14 nucleolar protein homolog (yeast)

NPM3

nucleophosmin/nucleoplasmin, 3

ODC1

ornithine decarboxylase 1

PDCD6

programmed cell death 6

PLAU

plasminogen activator, urokinase

RIOK3

RIO kinase 3 (yeast)

RRM1

ribonucleotide reductase M1

RRM2

ribonucleotide reductase M2 polypeptide

SHC4

SHC (Src homology 2 domain containing) family, member 4

SLC2A14

solute carrier family 2 (facilitated glucose transporter), member 14

SLC2A3

solute carrier family 2 (facilitated glucose transporter), member 3

SLC36A4

solute carrier family 36 (proton/amino acid symporter), member 4

SOCS1

Suppressor of cytokine signaling 1

TRIP13

thyroid hormone receptor interactor 13

TTC35

tetratricopeptide repeat domain 35

UHRF1

ubiquitin-like with PHD and ring finger domains 1

UPP1

uridine phosphorylase 1

USP1

ubiquitin specific peptidase 1

USP18

ubiquitin specific peptidase 18

VRK1

vaccinia related kinase 1

ZDHHC21

zinc finger, DHHC-type containing 21

  1. Aggressive gene signature used as a predictor of poor prognosis as determined by hierarchal clustering enrichment regime (see text, Figure 5).